FOLH1 and renal cell carcinoma: Sixteen full-text papers assessing the potential role of PSMA radioligands in the diagnostics of renal cell carcinoma (RCC) were reviewed [48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63].